COMET: Ducal Carcinoma in SITU - Clinical Trial

We are doing this study to compare the risks and benefits of the usual treatment approach for DCIS with a close disease- monitoring approach.

Ductal Carcinoma in Situ (DCIS)

Adult women over age 40 who:
- Have a new diagnosis of DCIS without invasive cancer
- Have no prior history of breast cancer in either breast

If you choose to join this study, you will:
- Be randomized (like a flip of a coin) into one of two treatment groups:
--- Group 1 will get traditional treatment with radiation, surgery, and chemotherapy
--- Group 2 will have close monitoring of their disease with possible chemotherapy

- Have tests, exams, and procedures that are part of your standard of care and for study purposes